The transcription factor ThPOK has been shown to be required and sufficient for CD4 + CD8 − thymocyte generation, yet the mechanism through which ThPOK orchestrates CD4 helper T cell lineage differentiation remains unclear. Here we utilized reporter mice to track expression of transcription factors in developing thymocytes. Distal promoter-driven Runx3 (Runx3d) expression was restricted to MHC class I-selected thymocytes. In ThPOK-deficient mice, Runx3d expression was de-repressed in MHCII-selected thymocytes, contributing to their redirection to the CD8 T cell lineage. In the absence of both ThPOK and Runx, redirection was prevented and cells potentially belonging to the CD4 lineage, presumably specified independently of ThPOK, were generated. Our results suggest that MHCII-selected thymocytes are directed towards the CD4 lineage independently of ThPOK, but require ThPOK to prevent Runx-dependent differentiation towards the CD8 lineage.
INTRODUCTION
Development of αβ T cells requires rearrangement of the Tcra and Tcrb loci and appropriate signals transduced via interactions between T cell receptors (TCR) on CD4 + CD8 + double positive (DP) thymocytes and peptide in the context of major histocompatibility complex (MHC) molecules on thymic stromal cells. Only a small proportion of DP thymocytes is selected for differentiation into mature cells that home to peripheral secondary lymphoid organs. This positive selection process is accompanied or followed by coordinated activation and/or repression of genes that program differentiation of the selected thymocytes to specific lineages of mature T cells. CD4 + helper T cells and CD8 + cytotoxic T cells comprise a Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms majority of mature αβ T lymphocytes in mice and humans. After positive selection, DP cells expressing MHC class I-or MHC class II-restricted TCRs undergo differentiation into CD8 + and CD4 + lineage T cells, respectively; this differentiation involves transcriptional downregulation of one or the other co-receptor1. CD4 expression is terminated in CD4 − CD8 + single positive (CD8SP) thymocytes through activation of the Cd4 silencer, a negative cisregulatory element in the Cd4 locus; Cd4 silencing is subsequently maintained by epigenetic mechanisms2,3. CD8 expression is transiently down-regulated in both MHCI-and MHCIIrestricted thymocytes and is selectively reactivated in MHCI-restricted CD8SP cells through stage-specific enhancers4. In addition to Cd4, Cd8a and Cd8b, other genes are selectively activated or repressed in each mature T cell lineage, and a major goal has been to elucidate how lineage-specific gene regulation is coordinated.
During early hematopoiesis, a balance between distinct lineage-specific transcription factors determines fates of mature cells derived from common multipotent progenitors5. Similar gene regulatory networks may regulate the CD4 versus CD8 lineage decision. The C2H2 type zinc finger transcription factor ThPOK (http://www.informatics.jax.org/javawi2/servlet/ WIFetch?page=markerDetail&key=18709), encoded by the Zbtb7b gene, is required and sufficient for generation of CD4SP thymocytes following positive selection6,7. hd/hd (helper deficient) mice, which harbor a mutation in ThPOK, lack CD4 + helper T cells, and thymocytes selected by MHCII are redirected to the CD8 + T cell lineage. Forced expression of ThPOK results in redirection of MHCI restricted thymocytes to the CD4 + T cell lineage6,7.
Whereas ThPOK exerts a dominant influence over the differentiation of CD4SP thymocytes, it is not clear if differentiation of CD8SP thymocytes requires such a pivotal factor or occurs by default if ThPOK is not up-regulated. We previously identified the Runx family of transcriptional regulators as crucial for Cd4 gene silencing associated with differentiation of the CD8 + cytotoxic T cell lineage8. Among the three Runx proteins that form heterodimers with the common subunit CBFβ (http://www.informatics.jax.org/javawi2/servlet/WIFetch? page=markerDetail&key=15686), Runx3 (http://www.informatics.jax.org/javawi2/servlet/ WIFetch?page=markerDetail&key=45178) is the primary mediator of heritable Cd4 silencing during development of the CD8SP lineage, and Runx1 (http:// www.informatics.jax.org/javawi2/servlet/WIFetch?page=markerDetail&key=45176) also contributes to partial Cd4 silencing in the absence of Runx3 (ref. 8, 9) . Conditional inactivation of both Runx1 and Runx3 at the DP stage of thymocyte differentiation resulted in a complete loss of CD8SP thymocytes, although generation of CD4SP thymocytes was still observed10. Runx3 protein is detected in CD8SP but not CD4SP thymocytes, even though Runx3 mRNA was up-regulated in both lineages following positive selection10,11. These findings suggest that Runx3 expression is regulated at least in part via posttranscriptional mechanisms. Runx transcripts are initiated at two distinct sites; Runx3 expression from the distal promoter is detected exclusively in CD8SP thymocytes, whereas CD4SP cells express only the proximal promoter-derived transcript that is not sufficient for protein synthesis10. These results, together with our previous finding that Runx1 inactivation alone exerts little influence on development of the CD8 + lineage10, suggest that the CD8 + lineage-specific requirement for Runx function is satisfied primarily by Runx310, and that activation of the Runx3 distal promoter (designated here as Runx3d) is a key event required for CD8 lineage differentiation of MHCI-restricted thymocytes. Even though it is not expressed in naïve peripheral CD4 + T cells, Runx3 protein is up-regulated in interferon (IFN)-γ-producing T helper type 1 (T H 1) cells, where it contributes to repression of the interleukin (IL)-4 (Il4) gene, but the mechanism for its regulation in these cells is not known12,13.
ThPOK expression in developing thymocytes is regulated by a cis-acting silencer element required to restrict ThPOK expression to the CD4 + lineage14,15. In the absence of this silencer, ThPOK is prematurely expressed in DP thymocytes, and all positively selected thymocytes differentiate into CD4 + lineage cells14. The ThPOK silencer is bound by Runx complexes, and ThPOK is prematurely expressed in pre-selection DP thymocytes in the absence of both Runx1 and Runx3 (ref. 14) . This result implies that ThPOK activity is required for diversion of MHCI-selected Runx-deficient thymocytes to the helper T cell lineage, and suggests that Runx proteins continue to suppress ThPOK expression following positive selection of MHCI-restricted thymocytes. However, a requirement for Runx complexes in lineage-specific ThPOK silencing has been disputed14,15.
To clarify the gene regulatory network governing lineage determination of αβ T cells, we generated knock-in reporter strains that facilitate single cell analysis of ThPOK and Runx3d expression in MHCI-and MHCII-selected thymocytes. By analyzing these reporter mice, we show here that ThPOK prevents up-regulation of Runx3 and other CD8 lineage-specific genes. We provide genetic evidence suggesting that ThPOK stabilizes the fate of MHCIIselected thymocytes that would otherwise be diverted to the CD8SP lineage due to constitutive Runx function. We also show that ThPOK is not required for the appearance of CD4SP cells in an environment in which MHCII-specific thymocytes are positively selected; this latter finding suggests that other factors act upstream of ThPOK to direct CD4 expression following positive selection.
RESULTS

Runx3d is required for Runx3 protein expression in CD8 + T cells
To visualize thymocytes expressing Runx3d mRNA, we generated a reporter allele (Runx3d YFP ) by replacing the first coding exon utilized by the Runx3 distal promoter with the yellow fluorescent protein (YFP) coding sequence ( Supplementary Fig. 1a , online). In accordance with previous analyses of Runx protein and mRNA expression10, YFP expression was detected in CD8 + T cells, but not in CD4 + T cells or B220 + cells in peripheral blood lymphocytes from Runx3d YFP/+ mice ( Supplementary Fig. 1b, online) . To determine whether Runx3 distal promoter activity is required for Runx3 protein expression in CD8 + T cells, we generated homozygous Runx3d YFP/YFP mice, in which distal promoterderived Runx3 expression was eliminated. Whereas germline deletion of both proximal promoter-and distal promoter-derived Runx3 results in neonatal lethality in the 129 or C57BL6 genetic background16,17, Runx3d YFP/YFP mice were viable and fertile, and showed no gross abnormality (data not shown). Runx3 protein was almost undetectable in CD8 + T cells, and was markedly reduced in T helper type (T H 1)-polarized activated CD4 + T cells from Runx3d YFP/YFP compared to Runx3d YFP/+ mice ( Fig. 1a and Supplementary Fig. 1c,d , online). Runx1 was up-regulated in Runx3-deficient CD8 + T cells from both Runx3 F/F Cd4-cre + and Runx3d YFP/YFP mice ( Fig. 1a and Supplementary Fig. 1d, online) . This result indicates that most of Runx3 protein is derived from the distal promoter-driven transcript both in CD8 + T cells and in T H 1-polarized CD4 + T cells, and that only a small amount of Runx3 protein is expressed from the proximal promoter in T cells. In CD8 + T cells from Runx3d YFP/YFP mice, Cd4 silencing was incomplete and there was no up-regulation of CD103 (integrin αE) expression, which was previously shown to be dependent on Runx3 (ref. 18) (Fig. 1b,c) . Thus, Runx3 expression from the distal promoter is required for Cd4 silencing and CD103 expression in CD8SP thymocytes.
To investigate regulation of Runx3d expression in developing thymocytes, we next examined YFP expression in a series of intermediate thymocyte subsets defined by CD4, CD8, TCRβ, CD69 and CD24 (HSA) expression ( Fig. 2a and Supplementary Fig. 2a,b Fig. 2c , online) [19] [20] [21] [22] [23] [24] [25] . At this stage, we observed 2-5 % of cells expressing YFP ( Fig. 2a and Supplementary Fig. 2d , online). These YFP + cells were absent in Runx3d YFP/+ mice on a B2m −/− background, indicating that Runx3d transcription is activated only in positively selected MHCI-restricted thymocytes ( Supplementary Fig. 2d , online). Following the CD4 + CD8 lo stage, MHCI-selected thymocytes become CD4 + CD8 + CD69 + TCRβ hi , and such cells are absent in mice lacking β2-microglobulin, an essential component of MHCI molecules (B2m −/− ) ( Supplementary Fig. 2e, online) . In contrast, MHCII-restricted thymocytes continue to down-regulate surface CD8 expression to become CD4 + CD8 − thymocytes before down-regulation of HSA. A majority of CD4 + CD8 + CD69 + TCRβ hi thymocytes expressed YFP, and cells with the highest surface TCRβ expression were brightest for YFP (Fig. 2a) . Mature HSA lo/− CD8SP thymocytes expressed a uniformly high amount of YFP (Fig. 2a) . YFP expression was not detected in the MHCII-restricted CD4 + CD8 − HSA hi population. These results indicate that Runx3d-YFP expression is highly restricted to MHCI-selected thymocytes, that it occurs largely following transit from the CD4 + CD8 lo stage, and that it specifically marks developing CD8SP thymocytes.
ThPOK expression specific to MHCII-restricted thymocytes
To visualize ThPOK expression in individual differentiating thymocytes, we generated a green fluorescent protein (GFP) knock-in allele of ThPOK (Zbtb7b GFP ) by replacing the entire exon 2 and exon 3 with GFP cDNA ( Supplementary Fig. 3a , online). In the periphery, all CD4 + T cells expressed high amounts of GFP, and a small proportion of CD8 + T cells expressed GFP, although in approximately 10-fold lower quantities ( Supplementary Fig. 4a , online)6,7. A large proportion of B220 + cells also expressed low amounts of GFP ( Supplementary Fig. 4a , online). In the thymus, GFP + cells were not detected in CD69 − preselected DP thymocytes (data not shown). Following positive selection, approximately half of the CD4 + CD8 lo cells and all mature CD4SP thymocytes expressed high quantities of GFP (Fig. 2b ). In the B2m −/− background, a larger proportion of the CD4 + CD8 lo thymocytes expressed GFP due to enrichment of MHCII-restricted cells (Fig. 2c) . At the CD4 + CD8 lo stage, distinct GFP hi and GFP lo populations were observed (Fig. 2b) . We noted slightly higher TCRβ expression in GFP hi cells, suggesting that MHCII-selected thymocytes undergo maturation while up-regulating ThPOK during the CD4 + CD8 lo stage (Fig. 2b) . Thus, expression of ThPOK occurs earlier in differentiation than that of Runx3d. Consistent with little GFP expression in peripheral CD8 + T cells, only a small subset of MHCI-selected thymocytes expressed low amounts of GFP. In Zbtb7b GFP/+ H2-Ab1 −/− mice, which lack MHCII molecules, approximately 5% of CD4 + CD8 lo , CD4 + CD8 + CD69 + TCRβ hi and CD4 lo/− CD8 + populations expressed low quantities of GFP ( Fig. 2c and data not shown). Approximately 4% of CD4 + CD8 + CD69 + TCRβ hi and CD4 lo/− CD8 + thymocytes coexpressed Runx3d-YFP and low amounts of ThPOK-GFP (Fig. 2d ), but we could not detect cells expressing high amounts of both reporters. Thus, strong expression of ThPOK and Runx3d in positively selected thymocytes may be mutually exclusive.
We also generated mice with a null allele of ThPOK ( Supplementary Fig. 3b , online) and examined Zbtb7b GFP/− mice that express no ThPOK protein. Zbtb7b GFP/− mice contained very few mature HSA lo/− CD4SP cells, but the total number of TCR hi HSA lo/− thymocytes remained normal ( Supplementary Fig. 4b , online). This phenotype is similar to that found in hd/hd mice26. As GFP expression in the CD69 + HSA hi CD4 + CD8 lo/− subpopulations was comparable between Zbtb7b GFP/+ mice and Zbtb7b GFP/− mice, ThPOK up-regulation during positive selection appeared unlikely to be dependent on ThPOK expression itself (Fig. 3a) . We observed a substantial amount of GFP expression in approximately two-thirds of CD8SP thymocytes and peripheral CD8 + T cells in Zbtb7b GFP/− mice (Fig. 2e ). GFP expression in CD8 + GFP + T cells in the periphery was approximately 3-fold lower compared to that in CD4 + T cells (data not shown). All CD8SP thymocytes in Zbtb7b GFP/− B2m −/− mice expressed GFP, indicating that they were MHCII-restricted cells redirected from the CD4SP lineage ( Supplementary Fig. 4c ). These findings suggest that MHCII-restricted positive selection is required and sufficient to turn on high ThPOK expression.
ThPOK blocks Runx3 expression
To determine whether there is cross regulation of ThPOK and Runx3 during thymocyte lineage specification, we examined expression of the ThPOK and Runx3d reporters in the absence of one or the other factor. ThPOK-GFP expression was unaffected by disruption of the distal promoter-derived Runx3 transcript or by transgenic overexpression of Runx3 (data not shown). In contrast, Runx3d-YFP was ectopically expressed in MHCII-restricted thymocytes in ThPOK-deficient mice, suggesting that ThPOK acts as an upstream negative regulator of Runx3 expression (Fig. 3b) . Approximately 30-40% of CD4 + CD8 − HSA hi thymocytes expressed Runx3d-YFP in the absence of ThPOK; these YFP + cells expressed the highest amount of TCRβ (Fig. 3b) . ThPOK-GFP was up-regulated despite the absence of ThPOK protein in MHCII-restricted CD4 + CD8 − HSA hi thymocytes, which were present only in MHCII-sufficient mice and were eventually redirected to the CD8SP lineage (Fig. 3a, c) . These findings suggest that Runx3d-YFP de-repression is an early indication of lineage redirection of ThPOK-deficient CD4SP "wannabe" cells to the CD8 + T cell lineage.
Lineage redirection due to a hypomorphic ThPOK allele
Our data imply that ThPOK expression following MHCII-restricted positive selection prevents expression of Runx3d. However, our analysis of ThPOK-GFP expression showed that a small proportion of CD8 + T cells also expressed ThPOK but differentiated into the cytotoxic lineage with normal Runx3d-YFP expression. This observation suggests that there is a threshold level of ThPOK expression that is required for helper T cell lineage commitment. To study the effect of reduced ThPOK quantities, we employed a hypomorphic Zbtb7b allele, in which the Pgk-neo r selection cassette was left in intron 1 of the Zbtb7b locus (Zbtb7b FN allele) ( Supplementary Fig. 3, online) . CD4 + CD8 − mature thymocytes and peripheral T cells were still present in Zbtb7b FN/− mice even though ThPOK expression was reduced by 80% compared to control CD4 + T cells as determined by q-RT-PCR, by ThPOK protein expression, and by GFP expression from a Zbtb7b GFP-neo allele (the Zbtb7b GFP allele with the Pgk-neo r cassette in the same context as in the Zbtb7b FN allele) (Fig. 4a,b and Supplementary Fig. 3, online) . As compared to Zbtb7b +/+ , Zbtb7b FN/+ , Zbtb7b +/− , or Zbtb7b FN/FN mice, Zbtb7b FN/− mice had fewer CD4 + CD8 − cells and more CD4 − CD8 + cells in HSA lo/− mature thymocyte and peripheral T cell populations, which resulted in an inverted CD4/CD8 ratio (Fig. 4c) . CD4 − CD8 + mature thymocytes and peripheral T cells, as well as CD4SP cells, were present in Zbtb7b FN/− B2m −/− mice, indicating that some MHCII-selected cells were redirected to the CD8SP lineage in the presence of an attenuated amount of ThPOK (Fig. 4c) . In addition to cells expressing CD4 or CD8, we observed atypical populations of mature thymocytes and T cells with a CD4 + CD8 + phenotype in Zbtb7b FN/− and Zbtb7b FN/− B2m −/− mice, suggesting that a reduced amount of ThPOK during thymocyte development affected the CD4 versus CD8 lineage decision (Fig. 4c) . These DP cells and a fraction of CD4 − CD8 + T cells expressed GFP in Zbtb7b FN/GFP mice, consistent with their being MHCII-restricted ( Supplementary Fig. 5a , online). These results suggest that during CD4SP thymocyte development a threshold amount of ThPOK expression is needed to mediate CD4SP thymocyte differentiation, and that when ThPOK amounts fall below this threshold, MHCII-restricted cells are diverted to a CD8 lineage fate. (Fig. 4d and Supplementary Fig. 5b, online) . Runx3 protein expression was higher in CD4 + CD8 + cells, and GFP expression from the Zbtb7b GFP-neo allele, which reflects ThPOK mRNA expression from the Zbtb7b FN allele, was inversely correlated with Runx3 protein expression ( Fig. 4d and Supplementary Fig. 5, online) . These results indicate that a high quantity of ThPOK is required to block Runx3 up-regulation and diversion of MHCIIrestricted thymocytes to the CD8SP lineage.
CD4SP cells can be generated in the absence of ThPOK
Our data indicated a correlation between Runx3 de-repression and redirection of MHCIIrestricted thymocytes to the cytotoxic lineage. To determine whether Runx complexes are required for lineage redirection occurring in the absence of ThPOK, we generated mice doubly deficient for ThPOK and CBFβ. We used the Lck-cre transgene to conditionally inactivate Cbfb because its later inactivation in DP thymocytes with Cd4-cre allows generation of CD8 + mature thymocytes (which de-repress CD4)12, most likely due to long half-life of the CBFβ protein. Conditional inactivation of Cbfb with Lck-cre allows thymocytes to proceed through beta selection and phenocopies loss of both Runx1 and Runx3 at the DP stage. HSA hi CD69 + and HSA hi TCRβ hi positively selected thymocytes were reduced by approximately 5-fold in Lck-cre + Cbfb F/F mice and Lckcre + Cbfb F/F Zbtb7b GFP/− mice as compared to littermate control or ThPOK-deficient mice (Fig. 5a,b) . Similar to our previous observation in Runx1 F/F Runx3 F/F Cd4-cre + mice10, CD4 − CD8 + mature thymocytes with intact CD4 silencing, that had escaped Cre-mediated inactivation of Cbfb, were present in Lck-cre + Cbfb F/F mice. Although almost all of the mature thymocytes were redirected to the CD8SP subset in Lck-cre + Cbfb +/+ Zbtb7b GFP/− mice, a majority of the mature HSA lo thymocytes in Lck-cre + Cbfb F/F Zbtb7b GFP/− mice were CD4 + CD8 − and were not redirected to the CD8 lineage (Fig. 5a) . We also observed a CD4 + CD8 − T cell population not redirected to the CD8 lineage in lymph nodes of Lckcre + Cbfb F/F Zbtb7b GFP/− mice (Fig. 5a ). The number of CD4 + CD8 − thymocytes and peripheral T cells were reduced compared to wild-type mice but were similar in Lckcre + Cbfb F/F Zbtb7b GFP/+ and Lck-cre + Cbfb F/F Zbtb7b GFP/− mice (Fig. 5b) . We do not believe that these cells represent a rare population of unconventional CD4SP thymocytes, as iNKT cells do not develop in the absence of Runx complexes27 and Foxp3 + regulatory T cells are severely reduced in both CBFβ-deficient mice and ThPOK-deficient mice (unpublished results). In addition, CD40L (CD154) was up-regulated upon stimulation of CD4 + T cells lacking both transcription factors, consistent with their being helper lineage cells ( Supplementary Fig. 6 , online). Thus these findings indicate that Runx complexes are required for redirection of MHCII-restricted thymocytes towards the CD8SP lineage in the absence of ThPOK, and ThPOK is not required for CD4 expression in mature MHCIIrestricted thymocytes and CD4 + peripheral T cells.
ThPOK represses genes specific for the CD8SP lineage
The finding of Runx3d de-repression in ThPOK-deficient MHCII-restricted thymocytes raises the possibility that other CD8 + lineage-specific genes may also be de-repressed in these cells. To assess this possibility, we compared gene expression between CD4 + CD8 − HSA hi GFP + thymocytes from Zbtb7b GFP/− and Zbtb7b GFP/+ mice. qRT-PCR analysis showed that Zbtb7b GFP/− cells expressed significantly higher amounts of transcripts that are normally expressed in the CD8SP lineage of wild-type mice, including Cd8a, Itgae, Nkg7, Cd160 and Prf1 (Fig. 6a) . In addition, unlike wild-type CD4 + T cells, a majority of Zbtb7b FN/− CD4 + T cells produced IFN-γ when stimulated with anti-CD3 and anti-CD28 in the absence IL-12 (Fig. 6b) . Expression of the CD8 lineage-specific IFN-γ-regulating transcription factor Eomes was significantly elevated in Zbtb7b FN/− compared to wild-type CD4 + T cells (Fig. 6c) . These findings suggest that a high amount of ThPOK expression is required during development of CD4 + T cells to block the CD8SP lineage-specific gene expression program.
Discussion
Despite extensive effort over the past two decades, the mechanism by which DP cells undergoing positive selection commit to either the CD4 + or CD8 + lineage is not yet understood. The discovery of the hd mouse, which harbors a mutation in the Zbtb7b gene that encodes ThPOK, clearly demonstrated that positive selection could occur independently of lineage commitment26,28. Subsequent studies have suggested that ThPOK serves as a "master regulator" that directs the differentiation of helper T cells6,7. This conclusion was based on findings that forced expression of ThPOK redirected MHCI-selected thymocytes to the CD4 + lineage, and that MHCII-selected cells adopted the CD8 + lineage fate in the absence of functional ThPOK. Furthermore, a defect in a Runx-dependent silencer within the Zbtb7b gene resulted in de-repression of ThPOK in DP cells and in redirection of MHCIselected thymocytes14. Here we showed that ThPOK is up-regulated in positively selected CD4 + CD8 lo thymocytes before induction of Runx3 in cells destined to become CD8 + T cells, that ThPOK represses expression of Runx3 in MHCII-selected cells transiting from the CD4 + CD8 lo to the CD4 + CD8 − stage, and, intriguingly, that MHCII-selected thymocytes can become CD4SP cells even in the absence of ThPOK and, hence, may be specified to the helper lineage independently of ThPOK. These results argue that ThPOK may not be a "master regulator" but rather that it reinforces the CD4 lineage decision, at least in part by repressing Runx3 and thus preventing cells from expressing CD8 + lineage-specific genes.
Among the three Runx proteins, Runx3 is the only one specifically expressed in the CD8 lineage, where it is transcribed from its distal promoter. We previously demonstrated that conditional inactivation of Runx3 resulted in de-repression of the Cd4 gene in CD8 lineage T cells, but not in loss of CD8SP thymocytes or in redirection of MHCI-restricted thymocytes to the CD4SP lineage 10. This is most likely explained by functional redundancy achieved upon compensatory up-regulation of Runx1, and, accordingly inactivation of both Runx1 and Runx3 in DP thymocytes resulted in complete loss of CD8 lineage cells and in lineage redirection10,14. The results thus imply that, in the absence of genetic manipulation, activation of the Runx3 distal promoter is critical for initiation of CD8SP development. In the current study, we showed that ThPOK suppresses Runx3d expression in MHCII-selected cells. Following positive selection, a large proportion of MHCII-restricted thymocytes within the CD4 + CD8 lo population expressed the ThPOK-GFP reporter, but the Runx3d-YFP reporter was not expressed by MHCI-restricted thymocytes until they differentiated further. ThPOK-deficient MHCII-restricted thymocytes, in contrast, de-repressed Runx3d after they up-regulated ThPOK-GFP reporter expression in CD4 + CD8 lo/− subsets. This observation suggests that CD4 + T cell differentiation requires high ThPOK expression that is initiated prior to Runx3 up-regulation. In the presence of insufficient amounts of ThPOK, MHCII-restricted thymocytes fail to block Runx3 expression and are redirected to the CD8SP lineage. These findings suggest that Runx3d transcription can be activated regardless of MHC restriction but is normally blocked by ThPOK in a CD4 + lineage-specific manner. Analysis of regulation of the Runx3 distal promoter may clarify the potential cross regulation between these two transcription factors.
In mice lacking both ThPOK and Runx complexes, lineage redirection of MHCII-restricted CD4SP cells no longer occurred, suggesting that the CD4 lineage can be specified even in the absence of ThPOK. Consistent with this interpretation, in preliminary studies we found that CD40L (CD154), which is expressed on the surface of wild-type activated CD4 + but not CD8 + T cells, was up-regulated in CD4 + CD8 − T cells lacking both ThPOK and CBFβ. This result appears at first to be inconsistent with observations of previous studies on lineage regulation by ThPOK and Runx. For example, de-repression of ThPOK in the absence of Runx complexes in DP cells resulted in diversion of MHCI-restricted cells to the CD4 + lineage14. However, this effect was not demonstrated to be dependent on ThPOK. Similar lineage diversion observed upon targeted deletion of the ThPOK silencer may have resulted in higher-than-normal amounts of ThPOK in MHCI-selected cells; this elevated ThPOK expression may thus have effectively phenocopied forced ThPOK expression in transgenic mice, and may have bypassed the transcriptional mechanisms that normally precede ThPOK up-regulation during CD4 lineage specification14.
Our results therefore suggest that signals initiated in DP thymocytes upon TCR interaction with peptide-loaded MHCII molecules specify differentiation to the CD4 + lineage prior to the activity of ThPOK, which is expressed in this lineage upon release of its silencing and, possibly, activation of lineage-restricted positive regulatory elements14. The signals and factors involved in specification of the CD4 + lineage and in induction of ThPOK remain to be defined. GATA3 another transcription factor known to be required for the differentiation of CD4 + lineage cells, is up-regulated earlier than ThPOK, at the CD69 + TCR lo DP stage29. In the absence of GATA3, MHCII-selected thymocytes are arrested at the CD4 + CD8 lo stage30. GATA3 or other unknown CD4 specification factors may be required for ThPOK up-regulation, although a GATA3 consensus binding sequence in the ThPOK silencer appears to be dispensable15.
These findings are consistent with the notion that there is reciprocal regulation of ThPOK and Runx complexes. Runx1 and Runx3 are required for ThPOK silencing in DP cells, although their role in ThPOK regulation following positive selection remains unclear. Specific expression of Runx3 in the CD8SP lineage raises the possibility that ThPOK silencing is maintained by Runx3 in MHCI-restricted thymocytes, and that ThPOK silencing is 'released' in MHCII-selected thymocytes that do not express Runx3. However, as ThPOK up-regulation in MHCII-selected thymocytes occurs earlier than Runx3 up-regulation in MHCI-selected thymocytes, it is unlikely that Runx3 determines lineage-specific ThPOK expression. Alternatively, it is possible that Runx1 may modulate ThPOK silencer activity following positive selection signals either by acting alone or in cooperation with other CD4SP specifying factors, such as GATA3. Indeed it has been demonstrated that Runx and GATA factors potentially interact with each other and synergistically regulate blood cell lineage decisions in Drosophila31,32.
The roles of ThPOK and Runx factors in the helper versus cytotoxic T cell lineage decision appear to be asymmetric. Whereas ThPOK represses Runx3 expression following positive selection, the Runx proteins do not appear to prevent ThPOK expression except at the DP stage. In contrast to the effect of forced expression of ThPOK, transgenic overexpression of Runx proteins fails to redirect MHCII-specific cells to the CD8 lineage. Therefore, following induction of ThPOK in CD4 lineage thymocytes, its expression appears to become resistant to Runx-mediated repression. This may be due to epigenetic changes or to active inhibition of the repressive effect of Runx complexes, which have been reported to remain associated with the ThPOK silencer even in CD4 + lineage cells14.
ThPOK is likely to function not only to repress Runx3 expression, but also to repress other factors involved in cytotoxic lineage commitment or to insulate genes involved in CD4 + lineage commitment from the effects of Runx expression. Thus, in the absence of ThPOK, not only Runx proteins but also other ThPOK target genes are likely involved in the diversion to the CD8 + lineage. Following intrathymic differentiation, ThPOK and Runx3 protein can be co-expressed in activated peripheral CD4 + T cells under T H 1 polarizing conditions12,13 (data not shown). The mechanism which permits Runx3 expression in mature cells in the presence of ThPOK is unknown, but may involve a dominant role for the transcription factor T-bet, which is required for Runx3 expression in T H 1 cells13. Effector helper T cell functions may depend on expression of both transcription factors.
The "kinetic signaling" model of CD4 vs. CD8 lineage choice33,34 proposes that, during the post-positive selection CD4 + CD8 lo stage, extended signaling due to interaction of CD4 with MHCII results in helper lineage specification. Our results are potentially consistent with this model, and are the first to demonstrate that the CD4 + CD8 lo thymocyte subpopulation is heterogeneous with respect to expression of ThPOK. It is hence possible that only those cells with prolonged signaling up-regulate ThPOK. These may also be cells that preferentially up-regulate GATA3 in response to MHCII29.
In summary, we have provided genetic evidence suggesting that ThPOK may not be essential for specification of the CD4SP lineage, while Runx complexes are required for lineage redirection in the absence of ThPOK. ThPOK plays an essential role to prevent commitment to the CTL lineage following MHCII-restricted selection, at least in part by inhibiting up-regulation of Runx3 from the distal promoter. Future studies are needed to identify factors necessary for CD4 + lineage specification prior to ThPOK induction, to determine if there is a basal differentiation state following positive selection by either MHCI or MHCII, and to elucidate the gene regulatory network governing thymocyte lineage diversification.
METHODS Mice
Cbfb, Runx3, and Runx1 conditional knockout mice were described previously8,12. B2m −/− mice35, H2-Ab1 −/− mice36, Cd4-cre and Lck-cre transgenic mice37 were purchased from Taconic Farms, and EIIa-cre transgenic mice38 were from the Jackson Laboratory. For targeted insertion of YFP into the Runx3 locus, genomic fragments for homologous arms were PCR amplified from a BAC clone (RP24-309N18) encompassing the Runx3 locus. A targeting vector was constructed such that a 46 nt Runx3 coding sequence starting with an initiating codon from the distal promoter transcript was replaced with the YFP coding sequence. The NotI linearized targeting vector was electroporated into embryonic stem cells and G418 and gancyclovir double resistant colonies were screened by PCR for homologous recombination at the 3' end. Positive clones were validated by Southern blot with BamHI digestion. Genomic fragments encompassing the Zbtb7b locus were excised from a BAC clone (RP23-126P10) and cloned into pBluescript. For targeted deletion or conditional targeting of Zbtb7b, a targeting vector was constructed to flank exon 2 and exon 3, containing the entire coding sequence of Zbtb7b, with loxP sites. The neomycin resistance cassette was inserted approximately 1.1 kb upstream of exon 2 in a forward orientation with an additional loxP site at its 5' end. SacII-linearized targeting vector was transfected into ES cells by electroporation. G418 and gancyclovir double resistant colonies were screened by Southern blotting. For generation of Zbtb7b F/+ mice, Zbtb7b FN/+ ES cells were transiently transfected by pMC-Cre to remove the neomycin resistance gene. The Zbtb7b − allele was obtained by crossing Zbtb7b FN/+ mice to EIIa-cre transgenic mice. All mice were maintained under specific pathogen free conditions in the Skirball Institute Animal Facility. All experiments were performed in accordance with the protocol approved by the IACUC at the NYU School of Medicine.
Flow cytometry
All monoclonal antibodies were purchased from eBioscience or BD Bioscience. Clone names for individual antibodies used in this study are as follows: anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-HSA (M1/69), anti-CD69 (H1.2F3), anti-CD103 (2E7), anti-CD154 (MR1). anti-IL-4 (11B11), anti-IFN-γ (XMG1.2). Single cell suspensions were stained with the antibodies and DAPI, and analyzed with a LSRII flow cytometer (BD Biosciences) equipped with 355 nm, 405 nm, 488 nm and 633 nm lasers. 510/20, 545/35, 495LP, and 525LP filters were used to separate GFP and YFP signals. Data were analyzed using Flowjo software (Tree Star). Cell sorting was performed with a FACS Aria (BD Biosciences). The purity of sorted samples was higher than 99%.
Real time PCR for gene expression analysis
Total RNA was prepared from sorted thymocytes or lymphocytes using Trizol (Invitrogen). cDNA was synthesized with Superscript reverse transcriptase (Invitrogen). Real time PCR analysis was performed as described previously10. Primers and Taqman probes for Gata3 and Zbtb7b were described previously6,39. Other primer sequences are listed in Supplementary Table 1, online. Gene expression was examined using 3 independent samples and statistical difference was tested using two-tailed T test with unequal variance assumption. P values smaller than 0.05 were considered significant.
Immunoblotting
FACS purified cells were washed once with PBS and lysed in buffer containing 150 mM NaCl, 2 mM EDTA, 20mM Tris-HCl (pH7.5), 10% glycerol and 1% NP-40. The lysate was cleared by centrifugation, denatured in 1 × Laemmli buffer and separated by SDS-PAGE. Anti-pan-Runx recognizing the C-terminus of Runx1 and Runx3 was described previously10. Anti-ThPOK was generated by immunizing rabbits with a recombinant GSTfusion protein containing amino acids 423-543 of ThPOK. Immunoblot was performed using crude serum. Anti-HMG1 was used to estimate loading.
T cell stimulation and intracellular staining
Purified CD4 + CD8 − CD25 − CD62L + CD44 lo naïve T cells were stimulated with plate-bound anti-CD3 (145-2C11, 1 µg/ml) and anti-CD28 (37.5.1, 5 µg/ml) for 3 days in the presence of recombinant mouse IL-2 (20 U/ml) and in the absence of IL-12. The cells were restimulated with PMA and ionomycin for 4 hours in the presence of GolgiPlug (BD Biosciences), fixed with 2% paraformaldehyde, permeabilized with 0.3% saponin, and intracellularly stained for IFN-γ and IL-4 in the presence of 0.03% saponin. (a) MHCII-restricted HSA hi CD69 + CD4 + CD8 lo/− ThPOK-GFP hi thymocytes from Zbtb7b GFP/+ (black columns) or Zbtb7b GFP/− (white columns) were purified using gates as shown in Fig. 3 , and expression of CD4 + lineage-specific genes (Cd4, St8si6, Zbtb7b and Gata3) and CD8 + lineage-specific genes (Cd8a, Itgae, Prf1, Gpr114, Nkg7 and Cd160) was examined by qRT-PCR. mRNA expression of individual genes was normalized against Hprt1 expression and average expression in Zbtb7b GFP/+ cells was set as 1. Hprt1-normalized Eomes mRNA expression is shown as average and standard deviations from three independent samples. Statistical difference was tested by two-tailed T test with assumption of unequal variance. Genes that showed a P value smaller than 0.05 are marked with asterisks in (a). Actual P values for individual genes were as follows: Cd4: 0.28,
